112 related articles for article (PubMed ID: 1477495)
21. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
Dobashi H; Seki S; Habu Y; Ohkawa T; Takeshita S; Hiraide H; Sekine I
Hepatology; 1999 Aug; 30(2):430-6. PubMed ID: 10421651
[TBL] [Abstract][Full Text] [Related]
22. Natural killer cells in the thymus. Studies in mice with severe combined immune deficiency.
Garni-Wagner BA; Witte PL; Tutt MM; Kuziel WA; Tucker PW; Bennett M; Kumar V
J Immunol; 1990 Feb; 144(3):796-803. PubMed ID: 2136898
[TBL] [Abstract][Full Text] [Related]
23. Suppression of B-cell differentiation by natural killer (asialo GM1+) cells in mice.
Suzuki S; Suzuki R; Onta T; Kumagai K
Nat Immun Cell Growth Regul; 1986; 5(2):75-89. PubMed ID: 3487716
[TBL] [Abstract][Full Text] [Related]
24. Hypothalamic control of the generation of mature natural killer lymphocytes in bone marrow and spleen of the mouse.
Belluardo N; Mudó G; Cardile V; Migliorati G; Riccardi C; Cella S; Bindoni M
Nat Immun Cell Growth Regul; 1990; 9(1):26-35. PubMed ID: 2184351
[TBL] [Abstract][Full Text] [Related]
25. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
[TBL] [Abstract][Full Text] [Related]
26. The NK-1.1(-) mouse: a model to study differentiation of murine NK cells.
Koo GC; Dumont FJ; Tutt M; Hackett J; Kumar V
J Immunol; 1986 Dec; 137(12):3742-7. PubMed ID: 3782794
[TBL] [Abstract][Full Text] [Related]
27. Depletion of IL-10- and TGF-beta-producing regulatory gamma delta T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells.
Seo N; Tokura Y; Takigawa M; Egawa K
J Immunol; 1999 Jul; 163(1):242-9. PubMed ID: 10384122
[TBL] [Abstract][Full Text] [Related]
28. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
Cho SG; Shuto Y; Soda Y; Nakazaki Y; Izawa K; Uchimaru K; Takahashi S; Tani K; Tojo A; Asano S
Exp Hematol; 2004 Dec; 32(12):1246-54. PubMed ID: 15588949
[TBL] [Abstract][Full Text] [Related]
29. In vivo function of natural killer cells as regulators of myeloid precursor cells in the spleen.
Hansson M; Petersson M; Koo GC; Wigzell H; Kiessling R
Eur J Immunol; 1988 Mar; 18(3):485-8. PubMed ID: 3258567
[TBL] [Abstract][Full Text] [Related]
30. Increase in immunogenicity and sensitivity to natural cell-mediated cytotoxicity following in vitro exposure of MCA105 tumor cells to ultraviolet radiation.
Begovic M; Herberman R; Gorelik E
Cancer Res; 1991 Oct; 51(19):5153-9. PubMed ID: 1913641
[TBL] [Abstract][Full Text] [Related]
31. Natural killer cell cytokine production, not cytotoxicity, contributes to resistance against blood-stage Plasmodium chabaudi AS infection.
Mohan K; Moulin P; Stevenson MM
J Immunol; 1997 Nov; 159(10):4990-8. PubMed ID: 9366426
[TBL] [Abstract][Full Text] [Related]
32. In vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. II. Separation of natural killer cells and cytotoxic T cells.
Le Gros GS; Herbert AG; Watson JD
Immunology; 1984 Jan; 51(1):103-13. PubMed ID: 6606615
[TBL] [Abstract][Full Text] [Related]
33. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-gamma/delta+ T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody.
Aramburu J; Balboa MA; Ramírez A; Silva A; Acevedo A; Sánchez-Madrid F; De Landázuri MO; López-Botet M
J Immunol; 1990 Apr; 144(8):3238-47. PubMed ID: 1691231
[TBL] [Abstract][Full Text] [Related]
34. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
[TBL] [Abstract][Full Text] [Related]
35. Gamma delta T cells in the pathobiology of murine acute graft-versus-host disease. Evidence that gamma delta T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality.
Ellison CA; MacDonald GC; Rector ES; Gartner JG
J Immunol; 1995 Nov; 155(9):4189-98. PubMed ID: 7594574
[TBL] [Abstract][Full Text] [Related]
36. Interleukin 3 is a major negative regulator of the generation of natural killer cells from bone marrow precursors.
Kalland T
J Immunol; 1986 Oct; 137(7):2268-71. PubMed ID: 2876040
[TBL] [Abstract][Full Text] [Related]
37. Physiology of natural killer cells. In vivo regulation of progenitors by interleukin 3.
Kalland T
J Immunol; 1987 Dec; 139(11):3671-5. PubMed ID: 3500227
[TBL] [Abstract][Full Text] [Related]
38. Kinetics of natural killer cell cytotoxicity during the graft-versus-host reaction. Relationship between natural killer cell activity, T and B cell activity, and development of histopathological alterations.
Ghayur T; Seemayer TA; Lapp WS
Transplantation; 1987 Aug; 44(2):254-60. PubMed ID: 3498241
[TBL] [Abstract][Full Text] [Related]
39. Overnight incubation of mouse spleen cells in recombinant IL-2 generates cytotoxic cells with NK characteristics from precursors enriched with or devoid of LGL.
Punturieri A; Velotti F; Piccoli M; Herberman RB; Frati L; Santoni A
Clin Exp Immunol; 1989 Jan; 75(1):155-60. PubMed ID: 2495199
[TBL] [Abstract][Full Text] [Related]
40. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R
J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
